| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-K | FY 2025 | 12/31/25 | 2/27/26 | → |
| 10-Q | Q3 2025 | 9/30/25 | 11/7/25 | → |
| 10-Q | Q2 2025 | 6/30/25 | 8/8/25 | → |
| 10-Q | Q1 2025 | 3/31/25 | 5/9/25 | → |
| 10-K | FY 2024 | 12/31/24 | 2/28/25 | → |
| 10-Q | Q3 2024 | 9/30/24 | 11/12/24 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 2/26/26 | Q1 FY2026 | → |
| 1/12/26 | Q4 FY2026 | → |
| 11/6/25 | Q4 FY2025 | → |
| 8/7/25 | Q3 FY2025 | → |
| 5/8/25 | Q2 FY2025 | → |
| 2/27/25 | Q1 FY2025 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 12/5/25 | Other | Unregistered Sales of Equity Securities | → |
| 6/18/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 3/12/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 12/6/24 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 7/22/24 | Other | Other Events | → |
| 6/18/24 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/2/26 | S-8 | S-8 | → |
| 12/10/25 | S-3ASR | S-3ASR | → |
| 12/5/25 | S-8 | S-8 | → |
| 12/5/25 | S-3 | S-3 | → |
| 10/21/25 | S-8 | S-8 | → |
| 4/24/25 | ARS | ARS | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 4/24/25 | DEFA14A | DEFA14A | → |
| 4/24/25 | DEF 14A | DEF 14A | → |
| 6/5/24 | DEFA14A | DEFA14A | → |
| 4/24/24 | DEFA14A | DEFA14A | → |
| 4/24/24 | DEF 14A | DEF 14A | → |
| 4/20/23 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| 3/3/26 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/6/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 3/2/26 | 144 | 144 | → |
| 2/17/26 | SCHEDULE 13G/A | SCHEDULE 13G/A | → |
| 2/3/26 | 144 | 144 | → |
| 2/2/26 | 144 | 144 | → |
| ↓ | |||
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health.